Population Pharmacokinetics of Remdesivir and GS-441524 in Hospitalized COVID-19 Patients

Population Pharmacokinetics of Remdesivir and GS-441524 in Hospitalized COVID-19 Patients

The objective of this study was to describe the population pharmacokinetics of remdesivir and GS-441524 in hospitalized coronavirus disease 2019 (COVID-19) patients. A prospective observational pharmacokinetic study was performed in non-critically ill hospitalized COVID-19 patients with hypoxemia. F...

Full description

Bibliographic Details
Main Authors: Bosma, L.B.E (Author), Leegwater, E. (Author), Moes, D.J.A.R (Author), Ottens, T.H (Author), van der Meer, I.M (Author), van Nieuwkoop, C. (Author), Wilms, E.B (Author)
Format: Article
Language:English
Published: NLM (Medline) 2022
Subjects:
COVID-19
pharmacokinetics
remdesivir
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items